Skip to content
Thursday 13 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE

Vaccine

  • More than 1m Londoners have received first dose of Covid vaccine

    February 4, 2021

    More than 1m people in London have received their first dose of the coronavirus vaccine, following concerns that the capital had been falling behind in the nation’s immunisation programme. Official figures published last night showed 1,011,490 Londoners have received their first dose of either the Astrazeneca/Oxford University or Pfizer/Biontech vaccines, while a further 60,658 people [...]

  • Boris Johnson: Hotel quarantine for arrivals to UK to be outlined tomorrow

    February 3, 2021

    Ministers will provide further details on the UK’s hotel quarantine policy tomorrow, the Prime Minister has announced. Speaking at a Downing Street press conference, Boris Johnson said the health secretary would set out the government’s plan for introducing a mandatory 10-day quarantine on arrivals to the UK from 30 countries. Johnson announced the measures last [...]

  • 10m people in UK have now received first dose of Covid vaccine

    February 3, 2021

    Ten million people in Britain have now received their first dose of the coronavirus vaccine, the health secretary has announced, in a major boost for hopes of a return to normality. Matt Hancock took to Twitter this afternoon to announce the “hugely significant milestone in our national effort against this virus”. “Every jab makes us [...]

  • Astrazeneca to roll out ‘next generation’ vaccine for Covid mutations by autumn

    February 3, 2021

    Astrazeneca aims to produce a “next generation” Covid-19 vaccine especially suited to new mutations as soon as the autumn, a senior executive said today. Mene Pangalos, a senior research chief at the British-Swedish firm, said Astrazeneca will start developing a new vaccine for the mutated strains and will look to make them public “as rapidly [...]

  • Covid antibodies last at least six months after infection

    February 3, 2021

    Coronavirus antibodies last for at least six months after infection for almost all people who have had the virus, according to a new study. A wide-scale study, by medical database UK Biobank, found that 99 per cent of participants who tested positive for coronavirus retained antibodies for at least three months, while 88 per cent [...]

  • Medical trial firm converts East End hotel as Covid19 nasal vaccine study ramps up

    February 3, 2021

    An Aim-listed medical trial firm is expanding in East London to free up space for two Covid-19 vaccine trials underway in Whitechapel.

  • Pfizer profit forecast gets a shot in the arm from successful Covid-19 vaccine

    February 2, 2021

    Pfizer has increased its profit forecast on the Covid-19 vaccine, although sales are below expectations

  • ‘More mutations of concern’ found in Bristol and Liverpool, says Matt Hancock

    February 2, 2021

    More Covid “mutations of concern” have been identified in Bristol and Liverpool, the health secretary has announced, as ministers scramble to contain new strains spreading around the country. Speaking in the Commons, Matt Hancock said 11 cases of mutant strains were identified in Bristol and 32 in Liverpool. The health secretary said ministers will roll [...]

  • Kent Covid variant has mutated again and may be immune to vaccine

    February 2, 2021

    The coronavirus variant first identified in Kent has acquired a mutation that may be partially resistant to vaccines, senior scientists have warned. The E484K mutation is the same change that has been identified in both the Brazilian and South African variants that have sparked international concern. Calum Semple, a member of the Scientific Advisory Group [...]

  • Prime Minister pushes for schools to reopen as ‘peak of infections passed’

    February 2, 2021

    Boris Johnson is pushing for schools to reopen as soon as possible after being told by the chief medical officer that the “peak of infections has passed”, according to reports. The Prime Minister has told ministers to prioritise children’s education as the government’s most immediate focus, with extra funding earmarked to help students falling behind. [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • …
  • Page 48
  • Next

Trending Articles

  • Government debt repayment ‘could rise to half’ of total taxes

  • Everest Group Announces Dividend

  • Moody’s Corporation Elects Keith Demmings to Board of Directors

  • Lattice to Deliver Keynote at 2026 OCP Global Summit

  • Martin Williams on his favourite Toast the City venues

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook